Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$78,519,677
+$4,427,337 QoQ
Shares Held
1,350,760
+5.9% QoQ
Ownership
0.908%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 329 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Jun 30, 2026CallValue
$1,459,063
CallShares
25,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. PCVX ranks #44 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in PCVX
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,459,063 | 25,100 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $78,519,677 | 1,350,760 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $74,092,340 | 1,275,036 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,458,561 | 25,100 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $1,158,114 | 25,100 | Call | Defined | 2026-03-25 | |
| 2025-12-31 | $49,744,456 | 1,078,120 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $35,133,079 | 975,377 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $682,710 | 21,000 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $30,386,055 | 934,668 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $43,322,123 | 1,147,302 | Shares | Defined | 2025-06-27 | |
| 2025-03-31 | $792,960 | 21,000 | Call | Defined | 2025-06-27 | |
| 2025-03-31 | $792,960 | 21,000 | Put | Defined | 2025-06-27 | |
| 2024-12-31 | $256,189,382 | 3,129,604 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $108,470,910 | 949,251 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $55,631,159 | 736,739 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $47,713,988 | 698,492 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $30,214,271 | 481,119 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $21,876,230 | 429,114 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $22,265,499 | 445,845 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $18,678,195 | 498,351 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $19,149,503 | 399,364 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $11,709,192 | 487,883 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $7,689,569 | 353,381 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $8,272,606 | 342,551 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,721,767 | 198,477 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $6,248,478 | 246,294 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $4,177,517 | 185,585 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,576,725 | 181,100 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,862,274 | 295,908 | Shares | Defined | 2021-02-12 | |
| 2020-06-30 | $2,763,472 | 87,424 | Shares | Defined | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||